Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria

Emerging evidence suggests that antibodies against merozoite proteins involved in P. falciparum invasion into the red blood cell (RBC) play an important role in clinical immunity to malaria. The protein family of parasite antigens known as P. falciparum Reticulocyte Binding Protein Homologue (PfRh)...

Full description

Bibliographic Details
Main Authors: Chris Y. H. Chiu, Julie eHealer, Jennifer K. Thompson, Lin eChen, Aiki eKaul, Laxman eSavergave, Arjun eRaghuwanshi, Connie S. N, Li Wai Suen, Peter M. Siba, Louis eSchofield, Ivo eMueller, Alan F Cowman, Diana Silvia Hansen
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00314/full
_version_ 1818364027544272896
author Chris Y. H. Chiu
Chris Y. H. Chiu
Julie eHealer
Jennifer K. Thompson
Lin eChen
Aiki eKaul
Laxman eSavergave
Arjun eRaghuwanshi
Connie S. N, Li Wai Suen
Peter M. Siba
Louis eSchofield
Louis eSchofield
Ivo eMueller
Ivo eMueller
Alan F Cowman
Alan F Cowman
Diana Silvia Hansen
Diana Silvia Hansen
author_facet Chris Y. H. Chiu
Chris Y. H. Chiu
Julie eHealer
Jennifer K. Thompson
Lin eChen
Aiki eKaul
Laxman eSavergave
Arjun eRaghuwanshi
Connie S. N, Li Wai Suen
Peter M. Siba
Louis eSchofield
Louis eSchofield
Ivo eMueller
Ivo eMueller
Alan F Cowman
Alan F Cowman
Diana Silvia Hansen
Diana Silvia Hansen
author_sort Chris Y. H. Chiu
collection DOAJ
description Emerging evidence suggests that antibodies against merozoite proteins involved in P. falciparum invasion into the red blood cell (RBC) play an important role in clinical immunity to malaria. The protein family of parasite antigens known as P. falciparum Reticulocyte Binding Protein Homologue (PfRh) is required for RBC invasion. PfRh5 is the only member within the PfRh family that cannot be genetically deleted, suggesting it plays an essential role in parasite survival. This antigen forms a complex with the cysteine-rich P. falciparum Rh5 interacting protein (PfRipr), on the merozoite surface during RBC invasion. The PfRh5 ectodomain sequence and a C-terminal fragment of PfRipr were cloned and expressed in E. coli and baculovirus-infected cells respectively. Immunization of rabbits with these recombinant proteins induced antibodies able to inhibit growth of various P. falciparum strains. Antibody responses to these proteins were investigated in a treatment-re-infection study conducted in an endemic area of Papua New Guinea (PNG) to determine their contribution to naturally acquired immunity. Antibody titres to PfRh5 but not PfRipr showed strong association with protection against P. falciparum clinical episodes. When associations with time to first infection were analysed, high antibody levels against PfRh5 were also found to be associated with protection from high-density infections but not from re-infection. Together these results indicate that PfRh5 is an important target of protective immunity and constitutes a promising vaccine candidate.
first_indexed 2024-12-13T21:57:50Z
format Article
id doaj.art-c14f84b2786042c2acccabc22bc2382a
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-13T21:57:50Z
publishDate 2014-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-c14f84b2786042c2acccabc22bc2382a2022-12-21T23:30:06ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2014-06-01510.3389/fmicb.2014.0031499462Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malariaChris Y. H. Chiu0Chris Y. H. Chiu1Julie eHealer2Jennifer K. Thompson3Lin eChen4Aiki eKaul5Laxman eSavergave6Arjun eRaghuwanshi7Connie S. N, Li Wai Suen8Peter M. Siba9Louis eSchofield10Louis eSchofield11Ivo eMueller12Ivo eMueller13Alan F Cowman14Alan F Cowman15Diana Silvia Hansen16Diana Silvia Hansen17The Walter and Eliza Hall Institute of Medical ResearchThe University of MelbourneThe Walter and Eliza Hall Institute of Medical ResearchThe Walter and Eliza Hall Institute of Medical ResearchThe Walter and Eliza Hall Institute of Medical ResearchGennova PharmaceuticalsGennova PharmaceuticalsGennova PharmaceuticalsThe Walter and Eliza Hall Institute of Medical ResearchPapua New Guinea Institute of Medical ResearchThe Walter and Eliza Hall Institute of Medical ResearchJames Cook UniversityThe Walter and Eliza Hall Institute of Medical ResearchUniversity of Barcelona, BarcelonaThe Walter and Eliza Hall Institute of Medical ResearchThe University of MelbourneThe Walter and Eliza Hall Institute of Medical ResearchThe University of MelbourneEmerging evidence suggests that antibodies against merozoite proteins involved in P. falciparum invasion into the red blood cell (RBC) play an important role in clinical immunity to malaria. The protein family of parasite antigens known as P. falciparum Reticulocyte Binding Protein Homologue (PfRh) is required for RBC invasion. PfRh5 is the only member within the PfRh family that cannot be genetically deleted, suggesting it plays an essential role in parasite survival. This antigen forms a complex with the cysteine-rich P. falciparum Rh5 interacting protein (PfRipr), on the merozoite surface during RBC invasion. The PfRh5 ectodomain sequence and a C-terminal fragment of PfRipr were cloned and expressed in E. coli and baculovirus-infected cells respectively. Immunization of rabbits with these recombinant proteins induced antibodies able to inhibit growth of various P. falciparum strains. Antibody responses to these proteins were investigated in a treatment-re-infection study conducted in an endemic area of Papua New Guinea (PNG) to determine their contribution to naturally acquired immunity. Antibody titres to PfRh5 but not PfRipr showed strong association with protection against P. falciparum clinical episodes. When associations with time to first infection were analysed, high antibody levels against PfRh5 were also found to be associated with protection from high-density infections but not from re-infection. Together these results indicate that PfRh5 is an important target of protective immunity and constitutes a promising vaccine candidate.http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00314/fullAntibodiesImmunityMalariaPlasmodium falciparumReticulocyte Binding proteing homologue 5
spellingShingle Chris Y. H. Chiu
Chris Y. H. Chiu
Julie eHealer
Jennifer K. Thompson
Lin eChen
Aiki eKaul
Laxman eSavergave
Arjun eRaghuwanshi
Connie S. N, Li Wai Suen
Peter M. Siba
Louis eSchofield
Louis eSchofield
Ivo eMueller
Ivo eMueller
Alan F Cowman
Alan F Cowman
Diana Silvia Hansen
Diana Silvia Hansen
Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
Frontiers in Microbiology
Antibodies
Immunity
Malaria
Plasmodium falciparum
Reticulocyte Binding proteing homologue 5
title Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
title_full Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
title_fullStr Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
title_full_unstemmed Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
title_short Association of antibodies to Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 with protection from clinical malaria
title_sort association of antibodies to plasmodium falciparum reticulocyte binding protein homologue 5 with protection from clinical malaria
topic Antibodies
Immunity
Malaria
Plasmodium falciparum
Reticulocyte Binding proteing homologue 5
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00314/full
work_keys_str_mv AT chrisyhchiu associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT chrisyhchiu associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT julieehealer associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT jenniferkthompson associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT linechen associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT aikiekaul associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT laxmanesavergave associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT arjuneraghuwanshi associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT conniesnliwaisuen associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT petermsiba associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT louiseschofield associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT louiseschofield associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT ivoemueller associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT ivoemueller associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT alanfcowman associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT alanfcowman associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT dianasilviahansen associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria
AT dianasilviahansen associationofantibodiestoplasmodiumfalciparumreticulocytebindingproteinhomologue5withprotectionfromclinicalmalaria